Development and Accuracy Evaluation of Gram Staining Analysis AI - Trial NCT06377592
Access comprehensive clinical trial information for NCT06377592 through Pure Global AI's free database. This phase not specified trial is sponsored by GramEye and is currently Recruiting. The study focuses on Bacterial Infections. Target enrollment is 18000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
GramEye
Timeline & Enrollment
N/A
May 10, 2023
Mar 31, 2027
Primary Outcome
Advanced level of blood culture Gram stain analysis AI accuracy,Ordinary level of blood culture Gram stain analysis AI accuracy
Summary
The investigators use Gram-stained specimens provided from clinical settings to develop and
 evaluate the accuracy of Gram staining analysis AI
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06377592
Non-Device Trial